Principal Investigator
Overview
Body Locations and Systems
Status
Recruiting
Start/End Dates
Locations
Gordon and Leslie Diamond Health Care Centre
Name/Title
PJ Johal, Study Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the efficacy and safety of selnoflast compared with placebo in participants with asthma.
Eligibility
You may be able to participate in this study if you:
- are between 19 to 80 years old
- have been diagnosed with asthma by a physician at least 12 months prior to screening
- are taking an inhaled medication which contains an inhaled corticosteroid (ICS), plus an additional controller medication including a long-acting bronchodilator (LABA) and have been consistent on this treatment for at least three months prior to screening (with no inhaler changes in the past four weeks prior to screening)
- have no history of smoking, or are a former smoker with less than 20 pack years (40 cigarettes per day for 10 years, or 20 cigarettes per day for 20 years)
- agree to refrain from heterosexual (male-female) intercourse or use at least one acceptable birth control method during the study treatment, until the safety follow-up visit
- are not pregnant, breast-feeding or planning to become pregnant
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
Body Locations and Systems
Status
Recruiting
Start/End Dates
Locations
Gordon and Leslie Diamond Health Care Centre
Name/Title
PJ Johal, Study Coordinator
Phone
Email Address
Purpose of Study
The purpose of this study is to evaluate the efficacy and safety of selnoflast compared with placebo in participants with asthma.
Eligibility
You may be able to participate in this study if you:
- are between 19 to 80 years old
- have been diagnosed with asthma by a physician at least 12 months prior to screening
- are taking an inhaled medication which contains an inhaled corticosteroid (ICS), plus an additional controller medication including a long-acting bronchodilator (LABA) and have been consistent on this treatment for at least three months prior to screening (with no inhaler changes in the past four weeks prior to screening)
- have no history of smoking, or are a former smoker with less than 20 pack years (40 cigarettes per day for 10 years, or 20 cigarettes per day for 20 years)
- agree to refrain from heterosexual (male-female) intercourse or use at least one acceptable birth control method during the study treatment, until the safety follow-up visit
- are not pregnant, breast-feeding or planning to become pregnant
Disclaimer
Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.
